Connexin-based signaling in acute myelogenous leukemia (AML)

Biochimica et Biophysica Acta - Biomembranes

Volumn 1798, Issue 1, 2010, Pages 1-8

  Foss, Brynjar ^a   Tronstad, Karl Johan ^b   Bruserud, Øystein ^c  

^a UNIVERSITY OF STAVANGER   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

^c HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

AML; Apoptosis; Chemosensitivity; Connexin; Gap junction; Hemichannel

Indexed keywords

ARSENIC TRIOXIDE; BETA CATENIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; DOCETAXEL; DOXORUBICIN; ETOPOSIDE; GAP JUNCTION PROTEIN; GROWTH FACTOR; METHOTREXATE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE; PACLITAXEL; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE C; PROTEIN TYROSINE KINASE; RETINOIC ACID; WNT PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CANCER STEM CELL; DRUG MECHANISM; DRUG SENSITIVITY; HUMAN; LEUKEMOGENESIS; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PROTEIN ANALYSIS; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION;

ACUTE DISEASE; APOPTOSIS; CELL COMMUNICATION; CONNEXINS; GAP JUNCTIONS; HUMANS; LEUKEMIA, MYELOID; MODELS, BIOLOGICAL; SIGNAL TRANSDUCTION;

EID: 71749114168     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamem.2009.10.014     Document Type: Review

References (103)

1. Shiozawa Y., Havens A.M., Pienta K.J., and Taichman R.S. The bone marrow niche: habitat to hematopoietic and mesenchymal stem cells, and unwitting host to molecular parasites. Leukemia 22 (2008) 941-950
2. Bruserud Ø. IL-4, IL-10 and IL-13 in acute myelogenous leukemia. Cytokines Cell. Mol. Ther. 4 (1998) 187-198
3. Ryningen A., Wergeland L., Glenjen N., Gjertsen B.T., and Bruserud O. In vitro crosstalk between fibroblasts and native human acute myelogenous leukemia (AML) blasts via local cytokine networks results in increased proliferation and decreased apoptosis of AML cells as well as increased levels of proangiogenic Interleukin 8. Leuk. Res. 29 (2005) 185-196
4. Hatfield K., Ryningen A., Corbascio M., and Bruserud Ø. Microvascular endothelial cells increase proliferation and inhibit apoptosis of native human acute myelogenous leukemia blasts. Int. J. Cancer 119 (2006) 2313-2321
5. Bruserud O., Ryningen A., Wergeland L., Glenjen N.I., and Gjertsen B.T. Osteoblasts increase proliferation and release of pro-angiogenic interleukin 8 by native human acute myelogenous leukemia blasts. Haematologica 89 (2004) 391-402
6. Glenjen N., Hatfield K., and Bruserud Ø. Coculture of native human acute myelogenous leukemia blasts with fibroblasts and osteoblasts results in an increase of vascular endothelial growth factor levels. Eur. J. Haematol. 74 (2005) 24-34
7. Konopleva M., Konoplev S., Hu W., Zaritskey A., Afanasiev B., and Andreeff M. Stromal cells prevent apoptosis of AML cells by up-regulation of anti-apoptotic proteins. Leukemia 16 (2002) 1713-1724
8. Oyamada M., Oyamada Y., and Takamatsu T. Regulation of connexin expression. Biochim. Biophys. Acta (BBA)-Biomembr. 1719 (2005) 6-23
9. Laird D.W. Life cycle of connexins in health and disease. Biochem. J. 394 (2006) 527-543
10. Oviedo-Orta E., and Evans H.W. Gap junctions and connexin-mediated communication in the immune system. Biochim. Biophys. Acta (BBA) - Biomembr. 1662 (2004) 102-112
11. Dorshkind K., Green L., Godwin A., and Fletcher W.H. Connexin-43-type gap junctions mediate communication between bone marrow stromal cells. Blood 82 (1993) 38-45
12. Cancelas J.A., Koevoet W.L.M., de Koning A.E., Mayen A.E.M., Rombouts E.J.C., and Ploemacher R.E. Connexin-43 gap junctions are involved in multiconnexin-expressing stromal support of hemopoietic progenitors and stem cells. Blood 96 (2000) 498-505
13. Foss B., Bruserud Ø., and Hervig T. Connexins are active participants of hematopoietic stem cell regulation. Stem Cells Dev. 18 (2009) 807-812
14. Mesnil M., Crespin S., Avanzo J.-L., and Zaidan-Dagli M.-L. Defective gap junctional intercellular communication in the carcinogenic process. Biochim. Biophys. Acta (BBA) - Biomembr. 1719 (2005) 125-145
15. Cronier L., Crespin S., Strale P.-O., Defamie N., and Mesnil M. Gap junctions and cancer: new functions for an old story. Antioxid. Redox Signal. 11 (2009) 323-338
16. Weber M., and Tykocinski M. Bone marrow stromal cell blockade of human leukemic cell differentiation. Blood 83 (1994) 2221-2229
17. Krenacs T., and Rosendaal M. Connexin43 gap junctions in normal, regenerating, and cultured mouse bone marrow and in human leukemias: their possible involvement in blood formation. Am. J. Pathol. 152 (1998) 993-1004
18. Paraguassu-Braga F.H., Borojevic R., Bouzas L.F., Barcinski M.A., and Bonomo A. Bone marrow stroma inhibits proliferation and apoptosis in leukemic cells through gap junction-mediated cell communication. Cell Death Differ. 10 (2003) 1101-1108
19. Li X., Xu Y.-B., Wang Q., Lu Y., Zheng Y., Wang Y.-C., Lübbert M., Zhao K.-W., and Chen G.-Q. Leukemogenic AML1-ETO fusion protein upregulates expression of connexin 43: the role in AML1-ETO-induced growth arrest in leukemic cells. J. Cell. Physiol. 208 (2006) 594-601
20. Gao F.-H., Wang Q., Wu Y.-L., Li X., Zhao K.-W., and Chen G.-Q. c-Jun N-terminal kinase mediates AML1-ETO protein-induced connexin-43 expression. Biochem. Biophys. Res. Commun. 356 (2007) 505-511
21. Hirabayashi Y., Yoon B.-I., Tsuboi I., Huo Y., Kodama Y., Kanno J., Ott T., Trosko J.E., and Inoue T. Protective role of connexin 32 in steady-state hematopoiesis, regeneration state, and leukemogenesis. Exp. Biol. Med. 232 (2007) 700-712
22. Huang R.-P., Hossain M., Huang R., Gano J., Fan Y., and Boynton A. Connexin 43 (cx43) enhances chemotherapy-induced apoptosis in human glioblastoma cells. Int. J. Cancer 92 (2001) 130-138
23. Abdelmohsen K., von Montfort C., Stuhlmann D., Arne Gerber P., Decking U., Sies H., Klotz L.-O., and Doxorubicin induces E. receptor-dependent downregulation of gap junctional intercellular communication in rat liver epithelial cells. Biol. Chem. 386 (2005) 217-223
24. Oktem G., Bilir A., Ayla S., Yavasoglu A., Goksel G., Saydam G., and Uysal A. Role of intercellular communications in breast cancer multicellular tumor spheroids after chemotherapy. Oncol. Res. (2006) 16
25. Chou Y., Tsai C.-H., Ueng K.-C., Tian T.-Y., Chen S.-C., and Yeh H.-I. Endothelial gap junctions are down-regulated by arsenic trioxide. Eur. J. Pharmacol. 569 (2007) 29-36
26. Ara C., Massimi M., and Devirgiliis C. Retinoic acid modulates gap junctional intercellular communication in hepatocytes and hepatoma cells. Cell. Mol. Life Sci. 59 (2002) 1758-1765
27. Tsujino T., Nagata T., Katoh F., and Yamasaki H. Inhibition of Balb/c 3T3 cell transformation by synthetic acyclic retinoid NIK-333; possible involvement of enhanced gap junctional intercellular communication. Cancer Detect. Prev. 31 (2007) 332-338
28. Alvarez R.H., and Kantarjian H.M. J.E. Cortes, The role of Src in solid and hematologic malignancies. Cancer 107 (2006) 1918-1929
29. Pahujaa M., Anikin M., and Goldberg G.S. Phosphorylation of connexin43 induced by Src: regulation of gap junctional communication between transformed cells. Exp. Cell Res. 313 (2007) 4083-4090
30. Plotkin L.I., and Bellido T. Biphosphonate-induced, hemichannel-mediated, anti-apoptosis through the Src/ERK pathway: a gap junction-independent action of connexin43. Cell. Commun. Adhes. 8 (2001) 377-382
31. Postma F.R., Hengeveld T., Alblas J., Giepmans B.N.G., Zondag G.C.M., Jalink K., and Moolenaar W.H. Acute loss of cell-cell communication caused by G protein-coupled receptors: a critical role for c-Src. J. Cell. Biol. 140 (1998) 1199-1209
32. Shen Y., Khusial P.R., Li X., Ichikawa H., Moreno A.P., and Goldberg G.S. Src utilizes Cas to block gap junctional communication mediated by connexin43. J. Biol. Chem. 282 (2007) 18914-18921
33. Fujimoto E., Sato H., Nagashima Y., Negishi E., Shirai S., Fukumoto K., Hagiwara H., Hagiwara K., Ueno K., Yano T., and Src family inhibitor A. (PP1) potentiates tumor-suppressive effect of connexin 32 gene in renal cancer cells. Life Sci. 76 (2005) 2711-2720
34. Gilliland D.G., and Griffin J.D. The roles of FLT3 in hematopoiesis and leukemia. Blood 100 (2002) 1532-1542
35. Mitina O., Warmuth M., Krause G., Hallek M., and Obermeier A. Src family tyrosine kinases phosphorylate Flt3 on juxtamembrane tyrosines and interfere with receptor maturation in a kinase-dependent manner. Ann. Hematol. 86 (2007) 777-785
36. Robinson L.J., Xue J., and Corey S.J. Src family tyrosine kinases are activated by Flt3 and are involved in the proliferative effects of leukemia-associated Flt3 mutations. Exp. Hematol. 33 (2005) 469-479
37. Miranda M.B., Redner R.L., and Johnson D.E. Inhibition of Src family kinases enhances retinoic acid induced gene expression and myeloid differentiation. Mol. Cancer Ther. 6 (2007) 3081-3090
38. Shaul Y.D., and Seger R. The MEK/ERK cascade: from signaling specificity to diverse functions. Biochim. Biophys. Acta (BBA) - Mol. Cell. Res. 1773 (2007) 1213-1226
39. Jia G., Mitra A.K., Cheng G., Gangahar D.M., and Agrawal D.K. Angiotensin II and IGF-1 regulate connexin43 expression via ERK and p38 signaling pathways in vascular smooth muscle cells of coronary artery bypass conduits. J. Surg. Res. 142 (2007) 137-142
40. Melchheier I., von Montfort C., Stuhlmann D., Sies H., and Klotz L.-O. Quinone-induced Cdc25A inhibition causes ERK-dependent connexin phosphorylation. Biochem. Biophys. Res. Commun. 327 (2005) 1016-1023
41. Ruch R., Trosko J.E., and Madhukar B.V. Inhibition of connexin43 gap junctional intercellular communication by TPA requires ERK activation. J. Cell. Biochem. 83 (2001) 163-169
42. Mograbi B., Corcelle E., Defamie N., Samson M., Nebout M., Segretain D., Fenichel P., and Pointis G. Aberrant connexin 43 endocytosis by the carcinogen lindane involves activation of the ERK/mitogen-activated protein kinase pathway. Carcinogenesis 24 (2003) 1415-1423
43. Cameron S.J., Malik S., Akaike M., Lerner-Marmarosh N., Yan C., Lee J.-D., Abe J.-i., and Yang J. Regulation of epidermal growth factor-induced connexin 43 gap junction communication by big mitogen-activated protein kinase 1/ERK5 but not ERK1/2 kinase activation. J. Biol. Chem. 278 (2003) 18682-18688
44. Towatari M., Iida H., Tanimoto M., Iwata H., Hamaguchi M., and Saito H. Constitutive activation of mitogen-activated protein kinase pathway in acute leukemia cells. Leukemia 11 (1997) 479-484
45. Siendones E., Barbarroja N., Torres L.A., Buendía P., Velasco F., Dorado G., Torres A., and López-Pedrera C. Inhibition of Flt3-activating mutations does not prevent constitutive activation of ERK/Akt/STAT pathways in some AML cells: a possible cause for the limited effectiveness of monotherapy with small-molecule inhibitors. Hematol. Oncol. 25 (2007) 30-37
46. Kim S.-C., Hahn J.-S., Min Y.-H., Yoo N.-C., Ko Y.-W., and Lee W.-J. Constitutive activation of extracellular signal-regulated kinase in human acute leukemias: combined role of activation of MEK, hyperexpression of extracellular signal-regulated kinase, and downregulation of a phosphatase, PAC1. Blood 93 (1999) 3893-3899
47. Milella M., Kornblau S.M., Estrov Z., Carter B.Z., Lapillonne H., Harris D., Konopleva M., Zhao S., Estey E., and Andreeff M. Therapeutic targeting of the MEK/MAPK signal transduction module in acute myeloid leukemia. J. Clin. Invest. 108 (2001) 851-859
48. Clevers H. Wnt/[beta]-catenin signaling in development and disease. Cell 127 (2006) 469-480
49. Simon M., Grandage V.L., Linch D.C., and Khwaja A. Constitutive activation of the Wnt//[beta]-catenin signalling pathway in acute myeloid leukaemia. Oncogene 24 (2005) 2410-2420
50. Ysebaert L., Chicanne G., Demur C., De Toni F., Prade-Houdellier N., Ruidavets J.B., Mansat-De Mas V., Rigal-Huguet F., Laurent G., Payrastre B., Manenti S., and Racaud-Sultan C. Expression of [beta]-catenin by acute myeloid leukemia cells predicts enhanced clonogenic capacities and poor prognosis. Leukemia 20 (2006) 1211-1216
51. Tickenbrock L., Schwable J., Wiedehage M., Steffen B., Sargin B., Choudhary C., Brandts C., Berdel W.E., Muller-Tidow C., and Serve H. Flt3 tandem duplication mutations cooperate with Wnt signaling in leukemic signal transduction. Blood 105 (2005) 3699-3706
52. De Toni F., Racaud-Sultan C., Chicanne G., Mas V.M.-D., Cariven C., Mesange F., Salles J.P., Demur C., Allouche M., Payrastre B., Manenti S., and Ysebaert L. A crosstalk between the Wnt and the adhesion-dependent signaling pathways governs the chemosensitivity of acute myeloid leukemia. Oncogene 25 (2006) 3113-3122
53. van der Heyden M.A., Rook M.B., Hermans M.M., Rijksen G., Boonstra J., Defize L.H., and Destree O.H. Identification of connexin43 as a functional target for Wnt signalling. J. Cell Sci. 111 (1998) 1741-1749
54. Liu X., Liu W., Yang L., Xia B., Li J., Zuo J., and Li X. Increased connexin 43 expression improves the migratory and proliferative ability of H9c2 cells by Wnt-3a overexpression. Acta Biochim. Biophys. Sinica 39 (2007) 391-398
55. Taneyhill L., and Pennica D. Identification of Wnt responsive genes using a murine mammary epithelial cell line model system. BMC Dev. Biol. 4 (2004) 6
56. Kuwabara M., Kakinuma Y., Katare R.G., Ando M., Yamasaki F., Doi Y., and Sato T. Granulocyte colony-stimulating factor activates Wnt signal to sustain gap junction function through recruitment of [beta]-catenin and cadherin. FEBS Lett. 581 (2007) 4821-4830
57. Wu J.-C., Tsai R.-Y., and Chung T.-H. Role of catenins in the development of gap junctions in rat cardiomyocytes. J. Cell. Biochem. 88 (2003) 823-835
58. Kohn A.D., and Moon R.T. Wnt and calcium signaling: [beta]-Catenin-independent pathways. Cell Calcium 38 (2005) 439-446
59. Suadicani S.O., Flores C.E., Urban-Maldonado M., Beelitz M., and Scemes E. Gap junction channels coordinate the propagation of intercellular Ca2+ signals generated by P2Y receptor activation. Glia 48 (2004) 217-229
60. Tõrõk K., Stauffer K., and Evans H. Connexin 32 of gap junctions contains two cytoplasmic calmodulin-binding domains. Biochem. J. 326 (1997) 479-483
61. Luo J., Manning B.D., and Cantley L.C. Targeting the PI3K-Akt pathway in human cancer: Rationale and promise. Cancer Cell 4 (2003) 257-262
62. Zhao S., Konopleva M., Cabreira-Hansen M., Xie Z., Hu W., Milella M., Estrov Z., Mills G.B., and Andreeff M. Inhibition of phosphatidylinositol 3-kinase dephosphorylates BAD and promotes apoptosis in myeloid leukemias. Leukemia 18 (2004) 267-275
63. Grandage V.L., Gale R.E., Linch D.C., and Khwaja A. PI3-kinase//Akt is constitutively active in primary acute myeloid leukaemia cells and regulates survival and chemoresistance via NF-kB, MAPkinase and p53 pathways. Leukemia 19 (2005) 586-594
64. Xu Q., Simpson S.-E., Scialla T.J., Bagg A., and Carroll M. Survival of acute myeloid leukemia cells requires PI3 kinase activation. Blood 102 (2003) 972-980
65. Plante I., Charbonneau M., and Cyr D.G. Activation of the integrin-linked kinase pathway downregulates hepatic connexin32 via nuclear Akt. Carcinogenesis 27 (2006) 1923-1929
66. Zhang F., Cheng J., Lam G., Jin D.K., Vincent L., Hackett N.R., Wang S., Young L.M., Hempstead B., Crystal R.G., and Rafii S. Adenovirus vector E4 gene regulates connexin 40 and 43 expression in endothelial cells via PKA and PI3K signal pathways. Circ. Res. 96 (2005) 950-957
67. Zhao Q., Tao J., Zhu Q., Jia P.M., Dou A.X., Li X., Cheng F., Waxman S., Chen G.Q., Chen S.J., Lanotte M., Chen Z., and Tong J.H. Rapid induction of cAMP/PKA pathway during retinoic acid-induced acute promyelocytic leukemia cell differentiation. Leukemia 18 (2004) 285-292
68. Yang X., Liu L., Sternberg D., Tang L., Galinsky I., DeAngelo D., and Stone R. The FLT3 internal tandem duplication mutation prevents apoptosis in interleukin-3-deprived BaF3 cells due to protein kinase A and ribosomal S6 kinase 1-mediated BAD phosphorylation at serine 112. Cancer Res. 65 (2005) 7338-7347
69. Kurinna S., Konopleva M., Palla S.L., Chen W., Kornblau S., Contractor R., Deng X., May W.S., Andreeff M., and Ruvolo P.P. Bcl2 phosphorylation and active PKC [alpha] are associated with poor survival in AML. Leukemia 20 (2006) 1316-1319
70. Hampson P., Chahal H., Khanim F., Hayden R., Mulder A., Assi L.K., Bunce C.M., and Lord J.M. PEP005, a selective small-molecule activator of protein kinase C, has potent antileukemic activity mediated via the delta isoform of PKC. Blood 106 (2005) 1362-1368
71. Platanias L.C. Map kinase signaling pathways and hematologic malignancies. Blood 101 (2003) 4667-4679
72. Warn-Cramer B.J., and Lau A.F. Regulation of gap junctions by tyrosine protein kinases. Biochim. Biophys. Acta (BBA) - Biomembr. 1662 (2004) 81-95
73. Salameh A., and Dhein S. Pharmacology of Gap junctions. New pharmacological targets for treatment of arrhythmia, seizure and cancer?. Biochim. Biophys. Acta (BBA) - Biomembr. 1719 (2005) 36-58
74. Yao J., Morioka T., and Oite T. PDGF regulates gap junction communication and connexin43 phosphorylation by PI 3-kinase in mesangial cells. Kidney Int. 57 (2000) 1915-1926
75. Moorby C., and Patel M. Dual functions for connexins: Cx43 regulates growth independently of gap junction formation. Exp. Cell Res. 271 (2001) 238-248
76. Schalper K.A., Palacios-Prado N., Retamal M.A., Shoji K.F., Martinez A.D., and Saez J.C. Connexin hemichannel composition determines the FGF-1-induced membrane permeability and free [Ca2+]i responses. Mol. Biol. Cell 19 (2008) 3501-3513
77. Eugenin E.A., Branes M.C., Berman J.W., and Saez J.C. TNF-{alpha} Plus IFN-{gamma} induce connexin43 expression and formation of gap junctions between human monocytes/macrophages that enhance physiological responses. J. Immunol. 170 (2003) 1320-1328
78. Ersvær E., Hampson P., Hatfield K., Ulvestad E., Wendelbo Ø., Lord J., Gjertsen B., and Bruserud Ø. T cells remaining after intensive chemotherapy for acute myelogenous leukemia show a broad cytokine release profile including high levels of interferon-γ that can be further increased by a novel protein kinase C agonist PEP005. Cancer Immunol. Immunother. 56 (2007) 913-925
79. Foss B., Ulvestad E., and Bruserud Ø. Platelet-derived growth factor (PDGF) in human acute myelogenous leukemia (AML): PDGF receptor expression, endogenous PDGF release and responsiveness to exogenous PDGF isoforms by in vitro cultured AML blasts. Eur. J. Haematology. 66 (2001) 365-376
80. Foss B., Mentzoni L., and Bruserud Ø. Effects of vascular endothelial growth factor (VEGF) on acute myelogenous leukemia blasts. J. Hematother. Stem Cell Res. 10 (2001) 81-94
81. Frostad S., and Bruserud Ø. In vitro effects of insulin-like growth factor-1 (IGF-1) on proliferation and constitutive cytokine secretion by acute myelogenous leukemia blasts. Eur. J. Haematol. 62 (1999) 191-198
82. Foss B., and Bruserud Ø. Platelet functions and clinical effects in acute myelogenous leukemia. Thromb. Haemost. 99 (2008) 27-37
83. Goodenough D.A., and Paul D.L. Beyond the gap: functions of unpaired connexon channels. Nat. Rev. Mol. Cell Biol. 4 (2003) 285-295
84. Jiang J.X., and Gu S. Gap junction- and hemichannel-independent actions of connexins. Biochim. Biophys. Acta (BBA) - Biomembr. 1711 (2005) 208-214
85. Conigrave A.D., van der Weyden L., Holt L., Jiang L., Wilson P., Christopherson R.I., and Morris M.B. Extracellular ATP-dependent suppression of proliferation and induction of differentiation of human HL-60 leukemia cells by distinct mechanisms. Biochem. Pharmacol. 60 (2000) 1585-1591
86. Vinken M., Vanhaecke T., Papeleu P., Snykers S., Henkens T., and Rogiers V. Connexins and their channels in cell growth and cell death. Cell. Signal. 18 (2006) 592-600
87. Plotkin L.I., Manolagas S.C., and Bellido T. Transduction of cell survival signals by connexin-43 hemichannels. J. Biol. Chem. 277 (2002) 8648-8657
88. Zhang Y.-W., Kaneda M., and Morita I. The Gap Junction-independent tumor-suppressing effect of connexin 43. J. Biol. Chem. 278 (2003) 44852-44856
89. Dang X., Doble B., and Kardami E. The carboxy-tail of connexin-43 localizes to the nucleus and inhibits cell growth. Mol. Cell. Chem. 242 (2003) 35-38
90. Gu S., Yu X.S., Yin X., and Jiang J.X. Stimulation of lens cell differentiation by gap junction protein connexin 45.6. Invest. Ophthalmol. Vis. Sci. 44 (2003) 2103-2111
91. Bruserud O., Gjertsen B.T., and Huang T.-s. Induction of differentiation and apoptosis-a possible strategy in the treatment of adult acute myelogenous leukemia. Oncologist 5 (2000) 454-462
92. Rodriguez-Sinovas A., Cabestrero A., Lopez D., Torre I., Morente M., Abellan A., Miro E., Ruiz-Meana M., and Garcia-Dorado D. The modulatory effects of connexin 43 on cell death/survival beyond cell coupling. Prog. Biophys. Mol. Biol. 94 (2007) 219-232
93. Krysko D., Leybaert L., Vandenabeele P., and D'Herde K. Gap junctions and the propagation of cell survival and cell death signals. Apoptosis 10 (2005) 459-469
94. Frantseva M.V., Kokarovtseva L., and Perez Velazquez J.L. Ischemia-induced brain damage depends on specific gap-junctional coupling. J. Cereb. Blood. Flow. Metab. 22 (2002) 453-462
95. Krutovskikh V.A., Piccoli C., and Yamasaki H. Gap junction intercellular communication propagates cell death in cancerous cells. Oncogene 21 (2002) 1989-1999
96. Contreras J.E., Sánchez H.A., Véliz L.P., Bukauskas F.F., Bennett M.V.L., and Sáez J.C. Role of connexin-based gap junction channels and hemichannels in ischemia-induced cell death in nervous tissue. Brain Res. Rev. 47 (2004) 290-303
97. Orrenius S., Zhivotovsky B., and Nicotera P. Regulation of cell death: the calcium-apoptosis link. Nat. Rev. Mol. Cell Biol. 4 (2003) 552-565
98. Patterson R.L., Boehning D., and Snyder S.H. Inositol 1,4,5-trisphosphate receptors as signal intergators. Annu. Rev. Biochem. 73 (2004) 437-465
99. Tronstad K.J., Gjertsen B.T., Krakstad C., Berge K., Brustugun O.T., Døskeland S.O., and Berge R.K. Mitochondrial-targeted fatty acid analog induces apoptosis with selective loss of mitochondrial glutathione in promyelocytic leukemia cells. Chem. Biol. 10 (2003) 609-618
100. Qin H., Shao Q., Thomas T., Kalra J., Alaoui-Jamali M.A., and Laird D.W. Connexin26 regulates the expression of angiogenesis-related genes in human breast tumor cells by both GJIC-dependent and -independent mechanisms. Cell. Commun. Adhes. 10 (2003) 387-393
101. Doble B.W., Dang X., Ping P., Fandrich R.R., Nickel B.E., Jin Y., Cattini P.A., and Kardami E. Phosphorylation of serine 262 in the gap junction protein connexin-43 regulates DNA synthesis in cell-cell contact forming cardiomyocytes. J. Cell. Sci. 117 (2004) 507-514
102. Ruiz-Meana M., Rodriguez-Sinovas A., Cabestrero A., Boengler K., Heusch G., and Garcia-Dorado D. Mitochondrial connexin43 as a new player in the pathophysiology of myocardial ischaemia-reperfusion injury. Cardiovasc. Res. 77 (2008) 325-333
103. Hagland H., Nikolaisen J., Hodneland L., Gjertsen B.T., Bruserud Ø., and Tronstad K.J. Targeting mitochondria in the treatment of human cancer: a coordinated attack against cancer cell energy metabolism and signalling. Expert Opin. Ther. Targets 11 (2007) 1055-1069